{"disease":{"id":"thrombocytopenic-purpura-immune","name":"thrombocytopenic purpura immune"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04057703","title":"Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia.","phase":"","overall_status":"COMPLETED","enrollment_count":454,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT00415532","title":"Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":234,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04070612","title":"National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.","phase":"","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT04070599","title":"Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT06287567","title":"Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}